Toggle navigation
TWunroll
TWunroll
faq
Contact US
Vk
biotechinvstr
$KALV the bigger thesis for what is only a $650M EV at pre market levels-Readthru to Prophylactic is the endgame. Ability to demo CLEAN efficacy AND safety w/ acute suggests
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree